Posters

Search Title by author or title

Real indications of femtosecond laser assisted cataract surgery (FLACS). What are the benefits over monofocal or trifocal IOLs?

Poster Details

First Author: A.Aristeidou GREECE

Co Author(s):    B. Almoghrabi                    

Abstract Details

Purpose:

To present the real indications of FLACS on routine cataract surgery and point out the benefits of this technology on monofocal and premium iol's. We also used it on some interesting cases like shallow anterior chamber, Fuchs dystrophy, white cataract, young patients and presbyopia correction candidates.

Setting:

We have been using the CATALYS Precision System (Johnson & Johnson Vision Care, Inc.) for two years in our clinic, for some simple routine cataract surgeries, as well as, for all our refractive cataract surgeries.

Methods:

Within two years we have performed 404 femtosecond cataract laser surgeries of 202 patients. 328 eyes were treated with trifocal iol and 76 eyes with monofocal iol. We used Finevision (Physiol) in half of the trifocal eyes and AcrySof IQ PanOptix (Alcon) in the other half. En Vista iol (Bausch and Lomb) monofocal lenses were used in all monofocal cases.

Results:

All cases were ended without any intraoperative complications. FLACS capsulorhexis was always cut and predictable. The lens fragmentation was also accurate as well as the corneal incisions, main and side ports. The astigmatic incisions were also accurate when the astigmatism was normal. In two patients (4 eyes) a repetition with excimer laser was needed, due to abnormal initial corneal astigmatism. All patients were happy at the end.

Conclusions:

FLACS is a highly recommended tool for performing refractive cataract surgery especially if there is corneal astigmatism. It is useful for monofocal as well as trifocal lenses to correct presbyopia and leads to an uncomplicated surgery. Moreover it was very helpful in young patients, white cataract, shallow anterior chamber, Fuchs's dystrophy and posterior polar cataract, to avoid posterior capsule rupture.

Financial Disclosure:

None

Back to Poster listing